GR1006121B - Η πρωτεϊνη serum amyloid p-component (sap,samp) ως προγνωστικος και διαγνωστικος δεικτης για τον προγεννητικο ελεγχο της τρισωμιας 21 (συνδρομο down) - Google Patents

Η πρωτεϊνη serum amyloid p-component (sap,samp) ως προγνωστικος και διαγνωστικος δεικτης για τον προγεννητικο ελεγχο της τρισωμιας 21 (συνδρομο down)

Info

Publication number
GR1006121B
GR1006121B GR20070100651A GR20070100651A GR1006121B GR 1006121 B GR1006121 B GR 1006121B GR 20070100651 A GR20070100651 A GR 20070100651A GR 20070100651 A GR20070100651 A GR 20070100651A GR 1006121 B GR1006121 B GR 1006121B
Authority
GR
Greece
Prior art keywords
protein
trisomy
samp
sap
component
Prior art date
Application number
GR20070100651A
Other languages
English (en)
Inventor
-
Original Assignee
��������������� ������� ��������� ������ (40%)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ��������������� ������� ��������� ������ (40%), filed Critical ��������������� ������� ��������� ������ (40%)
Priority to GR20070100651A priority Critical patent/GR1006121B/el
Priority to SI200830247T priority patent/SI2053407T1/sl
Priority to DK08386023.9T priority patent/DK2053407T3/da
Priority to EP08386023A priority patent/EP2053407B1/en
Priority to PT08386023T priority patent/PT2053407E/pt
Priority to AT08386023T priority patent/ATE500513T1/de
Priority to DE602008005228T priority patent/DE602008005228D1/de
Priority to ES08386023T priority patent/ES2362051T3/es
Priority to PL08386023T priority patent/PL2053407T3/pl
Publication of GR1006121B publication Critical patent/GR1006121B/el
Priority to HR20110371T priority patent/HRP20110371T1/hr
Priority to CY20111100524T priority patent/CY1112415T1/el

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/38—Pediatrics
    • G01N2800/385—Congenital anomalies
    • G01N2800/387—Down syndrome; Trisomy 18; Trisomy 13

Abstract

Η πρωτεΐνη serum amyloid P-component (SAP, SAMP) ως προγνωστικός και διαγνωστικός δείκτης για τον προγεννητικό έλεγχο της τρισωμίας 21 (σύνδρομο Down).
GR20070100651A 2007-10-26 2007-10-26 Η πρωτεϊνη serum amyloid p-component (sap,samp) ως προγνωστικος και διαγνωστικος δεικτης για τον προγεννητικο ελεγχο της τρισωμιας 21 (συνδρομο down) GR1006121B (el)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GR20070100651A GR1006121B (el) 2007-10-26 2007-10-26 Η πρωτεϊνη serum amyloid p-component (sap,samp) ως προγνωστικος και διαγνωστικος δεικτης για τον προγεννητικο ελεγχο της τρισωμιας 21 (συνδρομο down)
AT08386023T ATE500513T1 (de) 2007-10-26 2008-10-13 Die proteinserum-amyloid p-komponente (sap, samp) als prognose- und diagnose-marker für die pränatale diagnose von trisomie 21 (down syndrom)
DK08386023.9T DK2053407T3 (da) 2007-10-26 2008-10-13 Proteinet serum amyloid P-komponent (SAP, SAMP) som prognose og diagnose markør til prænatal diagnose af Trisomi 21 (Downs syndrom)
EP08386023A EP2053407B1 (en) 2007-10-26 2008-10-13 The protein serum amyloid P-component (SAP, SAMP) as prognostic and diagnostic marker for the prenatal diagnosis of Trisomy 21 (Down syndrome)
PT08386023T PT2053407E (pt) 2007-10-26 2008-10-13 Componente da prote?na amil?ide p s?rica (sap, samp) como marcador de progn?stico e diagn?stico para o diagn?stico pr?-natal de trissomia 21 (s?ndrome de down)
SI200830247T SI2053407T1 (sl) 2007-10-26 2008-10-13 Proteinska serumska amiloidna P-komponenta (SAP, SAMP) kot prognostični in diagnostični marker za prenatalno diagnozo trisomije 21 (Downovega sindroma)
DE602008005228T DE602008005228D1 (de) 2007-10-26 2008-10-13 Die Proteinserum-Amyloid P-Komponente (SAP, SAMP) als Prognose- und Diagnose-Marker für die pränatale Diagnose von Trisomie 21 (Down Syndrom)
ES08386023T ES2362051T3 (es) 2007-10-26 2008-10-13 La proteína componente de amiloide p de suero (sap, samp) como marcador de pronóstico y diagnóstico para el diagnóstico prenatal de la trisomía 21 (síndrome de down).
PL08386023T PL2053407T3 (pl) 2007-10-26 2008-10-13 Składnik surowiczego białka amyloidu P (SAP, SAMP) jako marker prognostyczny i diagnostyczny w prenatalnym diagnozowaniu trisomii 21 (zespołu Downa)
HR20110371T HRP20110371T1 (hr) 2007-10-26 2011-05-19 Proteinski serum amiloidne komponente p (sap, samp, swissprot br. p02743) kao prognostički i dijagnostički marker za prenatalnu dijagnozu trisomije 21 (downovog sindroma)
CY20111100524T CY1112415T1 (el) 2007-10-26 2011-05-31 Η πρωτεϊνη serum amyloid p-component (sap, samp) ως προγνωστικος και διαγνωστικος δεικτης για τον προγεννητικο ελεγχο της τρισωμιας 21 (συνδρομο down)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20070100651A GR1006121B (el) 2007-10-26 2007-10-26 Η πρωτεϊνη serum amyloid p-component (sap,samp) ως προγνωστικος και διαγνωστικος δεικτης για τον προγεννητικο ελεγχο της τρισωμιας 21 (συνδρομο down)

Publications (1)

Publication Number Publication Date
GR1006121B true GR1006121B (el) 2008-10-24

Family

ID=40030173

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20070100651A GR1006121B (el) 2007-10-26 2007-10-26 Η πρωτεϊνη serum amyloid p-component (sap,samp) ως προγνωστικος και διαγνωστικος δεικτης για τον προγεννητικο ελεγχο της τρισωμιας 21 (συνδρομο down)

Country Status (11)

Country Link
EP (1) EP2053407B1 (el)
AT (1) ATE500513T1 (el)
CY (1) CY1112415T1 (el)
DE (1) DE602008005228D1 (el)
DK (1) DK2053407T3 (el)
ES (1) ES2362051T3 (el)
GR (1) GR1006121B (el)
HR (1) HRP20110371T1 (el)
PL (1) PL2053407T3 (el)
PT (1) PT2053407E (el)
SI (1) SI2053407T1 (el)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104849471A (zh) * 2015-04-22 2015-08-19 戴勇 唐氏综合征图谱模型的构建方法
CN112924686A (zh) * 2019-12-05 2021-06-08 复旦大学 用于检测血清淀粉样蛋白a的免疫层析试纸条及其制备与检测方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030027216A1 (en) 2001-07-02 2003-02-06 Kiernan Urban A. Analysis of proteins from biological fluids using mass spectrometric immunoassay
AU2003263660A1 (en) 2003-08-29 2005-03-16 Pantarhei Bioscience B.V. Prenatal diagnosis of down syndrome by detection of fetal rna markers in maternal blood
WO2005078124A2 (de) 2004-02-16 2005-08-25 Proteosys Ag Diagnostische marker für krebs

Also Published As

Publication number Publication date
EP2053407A1 (en) 2009-04-29
EP2053407B1 (en) 2011-03-02
ES2362051T3 (es) 2011-06-27
HRP20110371T1 (hr) 2011-06-30
PL2053407T3 (pl) 2011-07-29
CY1112415T1 (el) 2015-12-09
ATE500513T1 (de) 2011-03-15
SI2053407T1 (sl) 2011-06-30
DE602008005228D1 (de) 2011-04-14
DK2053407T3 (da) 2011-06-20
PT2053407E (pt) 2011-05-10

Similar Documents

Publication Publication Date Title
Wilkinson et al. Type 1 Diabetic Children and siblings share a decrease in dendritic cell and monocyte numbers but are differentiated by expansion of CD4+ T cells expressing IL-17
WO2010053587A3 (en) Methods of monitoring conditions by sequence analysis
WO2005123779A3 (en) Antibodies binding to cd34+/cd36+ fetal but not to adult cells
ATE456055T1 (de) Diagnoseverfahren für erkrankungen im zusammenhang mit hirnschäden
MX2010006484A (es) Composiciones y metodos para detectar anticuerpos de infidelidad de transcripcion (tiab).
MX2011004767A (es) Metodos y composiciones para diagnosis y prognosis de lesion renal y falla renal.
IN2014MN02060A (el)
EP2634573A3 (en) A cartridge device for a measuring system for measuring viscoelastic characteristics of a sample liquid, a corresponding measuring system, and a corresponding method
WO2012110878A3 (en) Method of diagnosing cancer and diagnosis kit using measurement of nk cell activity
WO2011005893A3 (en) Biomarkers and methods for detecting alzheimer's disease
CA2820841C (en) Competitive biosensor having elevated sensitivity
EP2863220A3 (en) Reducing/oxidizing activity of maternal urine as indicator of fetal gender related characteristics
EP2081029A3 (en) Bio-markers for diagnosing diabetic retinopathy
WO2010078872A3 (en) Enrichment and identification of fetal cells in maternal blood and ligands for such use
DE602006013453D1 (de) Verfahren zur anreicherung fötaler zellen
EA201200603A1 (ru) Способ оценки жидкостного статуса пациента и/или чувствительности к удалению жидкости, контроллер и устройства
WO2010144553A3 (en) Methods for diagnosing blood vessel reocclusion
GR1006121B (el) Η πρωτεϊνη serum amyloid p-component (sap,samp) ως προγνωστικος και διαγνωστικος δεικτης για τον προγεννητικο ελεγχο της τρισωμιας 21 (συνδρομο down)
WO2009133197A3 (en) Levels of april in serum and use in diagnostic methods
WO2010033951A3 (en) Methods for identification and prediction of multiple sclerosis disease and therapy response
Den Hertog et al. Variation in the C-reactive protein gene is associated with serum levels of CRP in patients with acute ischemic stroke
MX2012005388A (es) Reactivos y metodos para detectar globulos blancos pnh tipo ii y su identificacion como factores de riesgo para transtornos trombolicos.
EP2508886A3 (en) Means and methods for classifying samples of multiple sclerosis patients
WO2007140971A3 (en) Cell adhesion proteins as biomarker for alzheimer's disease
WO2007143112A3 (en) Methods for diagnosing disorders and diseases associated with ryanodine receptors and methods for identifying compounds that affect ryanodine receptors

Legal Events

Date Code Title Description
PG Patent granted
ML Lapse due to non-payment of fees

Effective date: 20120503